MGRXMANGOCEUTICALS, INC.

Nasdaq www.mangorx.com


$ 0.38 $ -0.01 (-3.66 %)    

Thursday, 06-Jun-2024 13:34:13 EDT
QQQ $ 463.32 $ -0.16 (-0.03 %)
DIA $ 389.27 $ 0.80 (0.21 %)
SPY $ 534.63 $ -0.01 (0 %)
TLT $ 93.23 $ -0.14 (-0.15 %)
GLD $ 219.44 $ 1.61 (0.74 %)
$ 0.382
$ 0.37
$ 0.00 x 0
$ 0.38 x 100
$ 0.37 - $ 0.38
$ 0.14 - $ 2.38
1,809,180
na
9.48M
$ -3.28
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 04-01-2024 12-31-2023 10-K
3 10-27-2023 09-30-2023 10-Q
4 07-28-2023 06-30-2023 10-Q
5 05-10-2023 03-31-2023 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 mangorx-gets-patent-notice-of-allowance-in-japan-for-revolutionary-preventive-care-technology

Mangoceuticals, Inc. (NASDAQ:MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, an...

 mangorx-introduces-mojo-pharmaceutical-compounded-formula-featuring-enclomiphene-citrate-and-pregnenolone-for-treatment-of-low-testosterone-and-male-hormone-imbalances--sold-exclusively-on-mangorxs-website-on-a-subscription-basis-at-a-price-of-199-per-month

MOJO to be offered as an Oral Dissolvable Tablet (ODT) marketed to younger male demographic as an alternative to PRIME Testoste...

 mangoceuticals-develops-oral-glp-1s-stock-soars

Mangoceuticals announced the development of proprietary oral formulations of Semaglutide ("Slim") and Tirzepatide ("...

 mangoceuticals-q1-eps-010-up-from-023-yoy-sales-21409k-up-from-10072k-yoy

Mangoceuticals (NASDAQ:MGRX) reported quarterly losses of $(0.10) per share. This is a 56.52 percent increase over losses of $(...

 mangorx-acquires-patent-portfolio-for-total-of-20m-through-issuance-of-980k-of-6-series-c-convertible-preferred-shares

Mangoceuticals, Inc. (NASDAQ: MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, a...

 mangoceuticals-subsidiary-mangorx-mexico-executes-technical-agreement-with-mexican-pharmaceutical-manufacturer-for-initial-development-and-production-of-its-mango-erectile-dysfunction-products

Signifies the first major step towards the application process for the certification of itsMango ED oral dissolvable products b...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION